Psychedelic medicine in Germany

Free within clinical trial

Free within clinical trial

Free within clinical trial

Free within clinical trial

Amounts are not published. The group bills a per-day rate (Tagessatz) for general hospital services plus optional elective services (chief-physician treatment, single/double room). It admits privately insured, Beihilfe-entitled and self-paying patients, and statutory (GKV) insured patients in certain cases via the cost-reimbursement route under § 13(2) SGB V, with a statutory copayment of 10 euros per hospital day (max. 28 days per calendar year), as stated on oberbergkliniken.de/kostenuebernahme.

The clinic's ketamine page states that a single ketamine infusion in Frankfurt costs on average €200 to €300, and that as an off-label treatment the costs are currently not covered by statutory health insurers, while some private insurers reimburse partially or fully (mainop.de/behandlungen/ketamin/).

Prices are not published on the provider's website. Treatment is hospital-based at a public district hospital; admission to the depression programme follows referral (Einweisung) by an office-based physician, and registration for ketamine treatment must be submitted via the treating physician using the hospital's registration form.

Prices are not published on the provider's website; the university hospital provides general patient cost information pages but no fees for esketamine treatment.

No price published for Compassionate Use treatment; psilocybin (PEX010) supplied within the authorised Expanded Access Programme; treatment inpatient-only at a public-mandate institution

Covered by GKV for on-label TRD; see country guide

Covered by GKV for on-label TRD; see country guide

Covered by GKV for on-label TRD; see country guide

Covered by GKV for on-label TRD; see country guide

Covered by GKV for on-label TRD; see country guide

Covered by GKV for on-label TRD; see country guide

Covered by GKV for on-label TRD; see country guide

Covered by GKV for on-label TRD; see country guide

Covered by GKV for on-label TRD; see country guide

Covered by GKV for on-label TRD; see country guide

Covered by GKV for on-label TRD; see country guide

Covered by GKV for on-label TRD; see country guide

Covered by GKV for on-label TRD; see country guide

Covered by GKV for on-label TRD; see country guide

Covered by GKV for on-label TRD; see country guide

Covered by GKV for on-label TRD; see country guide

Covered by GKV for on-label TRD; see country guide

Outpatient nasal esketamine listed under the Privatambulanz (private outpatient clinic); the department also runs a GKV PIA — confirm billing route with the clinic

Private acute clinics for private insurance and self-payers; esketamine nasal spray named as an option subject to medical consultation and insurer cost coverage

Private acute psychiatric clinic for private insurance and self-payers

Private day clinic and outpatient unit for private insurance and self-payers

Covered by GKV for on-label TRD; see country guide

Covered by GKV for on-label TRD; see country guide

Private psychiatric practice; Spravato treatment with structured in-practice monitoring

Covered by GKV for on-label TRD; see country guide (the Grafing site also sees statutory-insurance patients)

Covered by GKV for on-label TRD; see country guide

Covered by GKV for on-label TRD; practice page states all insurers cover esketamine within the approved indication

Free within clinical trial

Free within clinical trial

Free within clinical trial

Free within clinical trial

Free within clinical trial

Free within clinical trial

Day-clinic (Tagesklinik) programme approx. EUR 15,000 for 6 weeks; private insurance (PKV) usually covers in full. Per-infusion pricing not published.

No price published; psilocybin (PEX010) administered within authorised Expanded Access Programme; treatment embedded in multi-week day-clinic programme (day clinic ca. EUR 15,000 / 6 weeks, PKV usually covers)

Free within clinical trial

Free within clinical trial

Free within clinical trial